Weissman and colleagues reported upregulation of CD24 gene expression in nearly all tumor types analyzed from TARGET and TCGA datasets and found that CD24 expression on breast and ovarian cancer cells inhibited phagocytosis by macrophages through engagement of Siglec‐10.36 Here, CD24 is linked to ovarian carcinoma.